Literature DB >> 23601011

Rho-associated coiled-coil kinase (ROCK) signaling and disease.

Alice V Schofield1, Ora Bernard.   

Abstract

The small Rho GTPase family of proteins, encompassing the three major G-protein classes Rho, Rac and cell division control protein 42, are key mitogenic signaling molecules that regulate multiple cancer-associated cellular phenotypes including cell proliferation and motility. These proteins are known for their role in the regulation of actin cytoskeletal dynamics, which is achieved through modulating the activity of their downstream effector molecules. The Rho-associated coiled-coil kinase 1 and 2 (ROCK1 and ROCK2) proteins were the first discovered Rho effectors that were primarily established as players in RhoA-mediated stress fiber formation and focal adhesion assembly. It has since been discovered that the ROCK kinases actively phosphorylate a large cohort of actin-binding proteins and intermediate filament proteins to modulate their functions. It is well established that global cellular morphology, as modulated by the three cytoskeletal networks: actin filaments, intermediate filaments and microtubules, is regulated by a variety of accessory proteins whose activities are dependent on their phosphorylation by the Rho-kinases. As a consequence, they regulate many key cellular functions associated with malignancy, including cell proliferation, motility and viability. In this current review, we focus on the role of the ROCK-signaling pathways in disease including cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601011     DOI: 10.3109/10409238.2013.786671

Source DB:  PubMed          Journal:  Crit Rev Biochem Mol Biol        ISSN: 1040-9238            Impact factor:   8.250


  75 in total

1.  Impaired cytoskeletal arrangements and failure of ventral body wall closure in chick embryos treated with rock inhibitor (Y-27632).

Authors:  Johannes W Duess; Prem Puri; Jennifer Thompson
Journal:  Pediatr Surg Int       Date:  2015-11-13       Impact factor: 1.827

2.  Rho-kinase expression in Hirschsprung's disease.

Authors:  David Coyle; Anne Marie O'Donnell; Nicolae Corcionivoschi; John Gillick; Prem Puri
Journal:  Pediatr Surg Int       Date:  2015-08-15       Impact factor: 1.827

Review 3.  Rho-kinase: regulation, (dys)function, and inhibition.

Authors:  Ehsan Amin; Badri Nath Dubey; Si-Cai Zhang; Lothar Gremer; Radovan Dvorsky; Jens M Moll; Mohamed S Taha; Luitgard Nagel-Steger; Roland P Piekorz; Avril V Somlyo; Mohammad R Ahmadian
Journal:  Biol Chem       Date:  2013-11       Impact factor: 3.915

4.  ROCK and Rho: Promising therapeutic targets to ameliorate pulmonary fibrosis.

Authors:  David W H Riches; Donald S Backos; Elizabeth F Redente
Journal:  Am J Pathol       Date:  2015-02-14       Impact factor: 4.307

5.  Mitochondrial fragmentation in excitotoxicity requires ROCK activation.

Authors:  Alejandro Martorell-Riera; Marc Segarra-Mondejar; Manuel Reina; Ofelia M Martínez-Estrada; Francesc X Soriano
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  In silico prediction of ROCK II inhibitors by different classification approaches.

Authors:  Chuipu Cai; Qihui Wu; Yunxia Luo; Huili Ma; Jiangang Shen; Yongbin Zhang; Lei Yang; Yunbo Chen; Zehuai Wen; Qi Wang
Journal:  Mol Divers       Date:  2017-08-02       Impact factor: 2.943

7.  Rho-Associated Coiled-Coil Kinase 1 Translocates to the Nucleus and Inhibits Human Cytomegalovirus Propagation.

Authors:  Erez Eliyahu; Osnat Tirosh; Martina Dobesova; Aharon Nachshon; Michal Schwartz; Noam Stern-Ginossar
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

8.  Inhibition of penile tunica albuginea myofibroblasts activity by adipose-derived stem cells.

Authors:  Hesong Jiang; Qingqiang Gao; Xiaoyan Che; Leilei Zhu; Zheng Zhang; Yun Chen; Yutian Dai
Journal:  Exp Ther Med       Date:  2017-09-21       Impact factor: 2.447

9.  MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

Authors:  Enqi Li; Jinli Zhang; Tianxiang Yuan; Baotong Ma
Journal:  Tumour Biol       Date:  2014-05-07

10.  ROCK2 mediates osteosarcoma progression and TRAIL resistance by modulating O-GlcNAc transferase degradation.

Authors:  Xueqiang Deng; Xuan Yi; Da Huang; Peng Liu; Leifeng Chen; Yunyan Du; Liang Hao
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.